DVA Company Profile and Key Details
DaVita Inc.
DVA Stock Price Chart
Stock Price Today
DaVita Inc. (DVA) stock declined over -0.15%, trading at $169.72 on NYSE, down from the previous close of $169.97. The stock opened at $170.47, fluctuating between $168.02 and $170.80 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Company Information
| Employees | 70000 |
| Beta | 0.89 |
| Sales or Revenue | $12.14B |
| 5Y Sales Change% | 1.002% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Care Facilities |
Frequently Asked Questions
DaVita Inc. (NYSE: DVA) stock price is $169.72 in the last trading session. During the trading session, DVA stock reached the peak price of $170.80 while $168.02 was the lowest point it dropped to. The percentage change in DVA stock occurred in the recent session was -0.15% while the dollar amount for the price change in DVA stock was -$0.26.
The NYSE listed DVA is part of Medical - Care Facilities industry that operates in the broader Healthcare sector. DaVita Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Jeffrey Allen Giullian
Chief Medical Officer of Kidney Care
Ms. Kathleen Alyce Waters
Chief Legal & Public Affairs Officer
Mr. James O. Hearty
Chief Compliance Officer
Mr. Javier J. Rodriguez
Chief Executive Officer & Executive Director
Mr. Joel Ackerman
Chief Financial Officer & Treasurer
Mr. Michael David Staffieri
Chief Operating Officer of Kidney Care
Mr. Atul Mathur
Executive Vice President of Global Operations
Mr. Jim Gustafson
Vice President of Investor Relations
Mr. John D. Winstel
Chief Accounting Officer
Dr. Abdulkareem Alsuwaida FRCPC, M.D., MSc
Chief Medical Officer - Saudi Operations
Mr. Kenneth Gardner Smith
Chief People Officer
Mr. Misha Palecek
Chief Transformation Officer of HealthCare Partners
Dr. Dinesh M. Kumar M.D.
Chief Medical Officer
DVA's closing price is 64.38% higher than its 52-week low of $103.55 where as its distance from 52-week high of $170.80 is -0.18%.
Number of DVA employees currently stands at 70,000.
Official Website of DVA is: https://www.davita.com
DVA could be contacted at phone 720 631 2100 and can also be accessed through its website. DVA operates from 2000 16th Street, Denver, CO 80202, United States.
DVA stock volume for the day was 201.49K shares. The average number of DVA shares traded daily for last 3 months was 771.69K.
The market value of DVA currently stands at $13.92B with its latest stock price at $169.72 and 82M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com